Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Leukemia Research, Verlag: Elsevier, Erscheinungsjahr: 2018, Jahrgang: 69, Heft: 6
- Ereignis
-
Veröffentlichung
- (wo)
-
Leipzig
- (wer)
-
Universitätsbibliothek Leipzig
- (wann)
-
2020
- Urheber
-
Grohmann, Theresa
Penke, Melanie
Petzold-Quinque, Stefanie
Schuster, Susanne
Richter, Sandy
Kiess, Wieland
Garten, Antje
- URN
-
urn:nbn:de:bsz:15-qucosa2-385901
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Grohmann, Theresa
- Penke, Melanie
- Petzold-Quinque, Stefanie
- Schuster, Susanne
- Richter, Sandy
- Kiess, Wieland
- Garten, Antje
- Universitätsbibliothek Leipzig
Entstanden
- 2020
Ähnliche Objekte (12)
The C. elegans p53 pathway
The C. elegans p53 pathway
The p53 network in chronic lymphocytic leukemia
Investigation of the ATM/p53 signaling pathway in primary leukemic B cells isolated from patients with chronic lymphocytic leukemia
X-Ray Treatment of Chronic Leukemia
Current treatment of juvenile myelomonocytic leukemia
Treatment-free remission in chronic myeloid leukemia
Optimal programs of pathway control: dissecting the influence of pathway topology and feedback inhibition on pathway regulation
Capitalizing on paradoxical activation of the mitogen-activated protein kinase pathway for treatment of Imatinib-resistant mast cell leukemia
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
Model-based optimal treatment schedules for acute leukemia
The C. elegans p53 pathway
The C. elegans p53 pathway
The p53 network in chronic lymphocytic leukemia
Investigation of the ATM/p53 signaling pathway in primary leukemic B cells isolated from patients with chronic lymphocytic leukemia
X-Ray Treatment of Chronic Leukemia
Current treatment of juvenile myelomonocytic leukemia
Treatment-free remission in chronic myeloid leukemia
Optimal programs of pathway control: dissecting the influence of pathway topology and feedback inhibition on pathway regulation
Capitalizing on paradoxical activation of the mitogen-activated protein kinase pathway for treatment of Imatinib-resistant mast cell leukemia
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
Model-based optimal treatment schedules for acute leukemia
The C. elegans p53 pathway
The C. elegans p53 pathway
The p53 network in chronic lymphocytic leukemia
Investigation of the ATM/p53 signaling pathway in primary leukemic B cells isolated from patients with chronic lymphocytic leukemia
X-Ray Treatment of Chronic Leukemia
Current treatment of juvenile myelomonocytic leukemia
Treatment-free remission in chronic myeloid leukemia
Optimal programs of pathway control: dissecting the influence of pathway topology and feedback inhibition on pathway regulation
Capitalizing on paradoxical activation of the mitogen-activated protein kinase pathway for treatment of Imatinib-resistant mast cell leukemia
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia